New and Investigational Treatment Options for Ischemic Stroke

We conducted a MEDLINE search of new treatment strategies and experimental agents for treating acute ischemic stroke published from 1989–1996. Clinical trials involving thrombolytics, glutamine release inhibition, N‐methyl‐d‐aspartate receptor antagonism, opioid antagonism, calcium channel blockade,...

Full description

Saved in:
Bibliographic Details
Published in:Pharmacotherapy 1997-09, Vol.17 (5), p.959-969
Main Authors: Ryan, Melody, Rhoney, Denise H., Luer, Mark S., Hatton, Jimmi
Format: Article
Language:English
Subjects:
Animals
Biological and medical sciences
Cardiovascular system
Cerebrovascular Disorders - physiopathology
Cerebrovascular Disorders - therapy
Drugs, Investigational - therapeutic use
Fibrinolytic Agents - therapeutic use
Humans
Medical sciences
Miscellaneous
Neurology
Pharmacology. Drug treatments
Vascular diseases and vascular malformations of the nervous system
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We conducted a MEDLINE search of new treatment strategies and experimental agents for treating acute ischemic stroke published from 1989–1996. Clinical trials involving thrombolytics, glutamine release inhibition, N‐methyl‐d‐aspartate receptor antagonism, opioid antagonism, calcium channel blockade, free radical scavenging, membrane stabilization, intercellular adhesion molecule‐1 antagonism, ganglioside administration, and growth factor administration were included. Basic research articles were selected based on progress of the therapeutic class toward clinical trials. Approval of tissue plasminogen activator indicates progress in new treatments for acute ischemic stroke. Experimental therapies with potential may become available soon. Recognizing signs and symptoms of stroke is crucial to ensure prompt administration of these agents. The time to diagnosis determines the therapeutic approach for acute ischemic stroke. (Pharmacotherapy 1997;17(5):959–969)
ISSN:0277-0008
1875-9114
DOI:10.1002/j.1875-9114.1997.tb03785.x